MCP: Study shows long-term effects of weight loss on the proteome
As hard as weight loss is, long-term maintenance can be even more of a challenge. But in the journal 麻豆传媒色情片 & Cellular Proteomics indicates that the hard work of maintaining weight loss can pay previously unknown health dividends.
Proteomics researchers found that many plasma proteins, such as myoglobin, shown at left, increase in nonenzymatic glycation after patients lose weight. It takes six months to a year of sustained weight loss for glycation to drop below baseline levels. PDB / S.E. Phillips
Using plasma samples from a study that followed people as they lost weight and worked to keep it off, researchers at a Swiss proteomics company called Biognosys, in collaboration with a team at Nestl茅, studied how weight loss affected participants’ blood proteome. They observed that while chronic inflammation subsides immediately after weight loss, it takes some time for added beneficial effects to kick in.
The diet, obesity and genetics study, or for short, was designed to test the benefit of various diets in maintaining weight loss. Among the 550 participants who lost 8 percent or more of their starting weight and stayed in the study for another six months, researchers , those who followed a high-protein, low-glycemic-index diet were most successful at keeping it off.
More recently, researchers at led by Lukas Reiter used a streamlined proteomics approach to analyze patient plasma samples from the start of the study, the end of its eight-week weight-loss phase, and six and 12 months into the maintenance phase. Consistent with other weight-loss studies, the team saw a dramatic, lasting drop in inflammatory signaling linked to atherosclerosis and an increase in lipid metabolism soon after weight loss.
Because of the depth of their proteome coverage, the Biognosys researchers could add a look at protein glycation. Nonenzymatic glycation occurs when high concentrations of sugar react with proteins in the plasma. Many of the glycated proteins that changed significantly during weight loss, including albumin, myoglobin and some apolipoproteins, were unexpectedly more abundant after the study’s initial weight-loss phase. It took more than six months on the weight-maintenance diet for those glycated proteins to drop back below their baseline levels. Because glycated proteins can activate the immune system, the researchers wrote, the effect of longer-term weight loss is positive.
In future studies, the researchers who own the data hope to move from looking at the whole cohort’s proteome to correlating each study participant’s outcomes with the composition of that individual’s proteome at baseline in search of biomarkers that could help predict how future dieters will fare. Meanwhile, the Biognosys team wants to use its analytic abilities to power high-throughput proteomics for clinical trials.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

How scientists identified a new neuromuscular disease
NIH researchers discover Morimoto鈥揜yu鈥揗alicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer鈥檚 spaghetti proteins
MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting 鈥渦ndruggable鈥 molecules.

How HCMV hijacks host cells 鈥 and beyond
Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.